# FDA Inspection 1081592 - Albemarle US, Inc. - January 25, 2019

Source: https://www.keypedia.com/records/fda_inspections/albemarle-us-inc/8accb262-a05c-45ea-add0-d18a4a3876a5
Source feed: FDA_Inspections

> FDA Inspection 1081592 for Albemarle US, Inc. on January 25, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1081592
- Company Name: Albemarle US, Inc.
- Inspection Date: 2019-01-25
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1286354 - 2025-09-08](https://www.keypedia.com/records/fda_inspections/albemarle-us-inc/9f9d7ded-08ea-487a-b68a-de7415011ae4)
- [FDA Inspection 1286354 - 2025-09-08](https://www.keypedia.com/records/fda_inspections/albemarle-us-inc/03c55c83-23b7-45d8-9fe6-9b8b676d0c9b)
- [FDA Inspection 919051 - 2015-03-12](https://www.keypedia.com/records/fda_inspections/albemarle-us-inc/63de662f-b4da-4b58-b39b-eca64cf71d11)
- [FDA Inspection 725849 - 2011-05-19](https://www.keypedia.com/records/fda_inspections/albemarle-us-inc/16980859-bcc6-4a9c-abee-0daf4f9b09ed)
- [FDA Inspection 573068 - 2009-03-31](https://www.keypedia.com/records/fda_inspections/albemarle-us-inc/4569e9df-b69c-4dad-b316-9b71b2324738)

Company: https://www.keypedia.com/companies/albemarle-us-inc/336600a7-808b-4d7d-bfc0-7a9e728aa0aa

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c